GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

For the first time, researchers at Phoenix's Barrow Neurological Institute have collected and displayed together the ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

Citation: Vesalius' historical 'manikins' displayed together for first time: A collection of works for historical surgery training (2024, November 4) retrieved 8 November 2024 from https ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

The research article - Vesalius and His Manikin: An Enduring Influence on Modern Anatomic Teaching – was published in the October 17, 2024, volume of Neurosurgery. The most prominent anatomist ...